Literature DB >> 16110288

Clinical and pathological features of glycogen-rich clear cell carcinoma of the breast.

Hajime Kuroda1, Goi Sakamoto, Kiyoshi Ohnisi, Shinji Itoyama.   

Abstract

BACKGROUND: Twenty cases of invasive ductal carcinoma of the breast with a pure or partial glycogen-rich clear cell carcinoma(GRCC)component are reported. GRCC of the breast is composed almost entirely of polygonal cells with clear cytoplasm. These contain large amounts of partly water-soluble glycogen.
METHODS: The cases were analyzed using various parameters, including age at presentation, tumor size, tumor grade, axillary lymph node and Her2/neu status.
RESULTS: Between 1990 and 2004, 723 patients with primary breast carcinomas were treated and clinicopathologic analysis was performed. 20 cases were identified as GRCC among the 723 cases. The patients' age at presentation ranged from 33 to 68 years (mean, 52 years). Tumor size ranged from 1 to 6.5 cm (mean, 2.6 cm); 35% (7 of 20) of cases that underwent axillary dissection had positive lymph nodes. Among 15 of 20 cases who were followed for 1-72 months, 5 cases died from their breast carcinoma within 5 years following the diagnosis.
CONCLUSION: Our series included more small size carcinomas than did previous series. Lymph node status does not appear to be markedly different from that of the usual invasive ductal carcinomas. Her2/neu expression was similar to that found in common breast carcinomas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16110288     DOI: 10.2325/jbcs.12.189

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  12 in total

1.  Glycogen-rich clear cell carcinoma of the breast: a case report.

Authors:  Yuji Mizukami; Teruhiko Takayama; Akihiro Takemura; Katsuhiro Ichikawa; Masahisa Onoguchi; Takao Taniya
Journal:  J Med Ultrason (2001)       Date:  2009-03-14       Impact factor: 1.314

2.  Intraductal glycogen-rich clear cell carcinoma of the breast: a rare presentation and review of the literature.

Authors:  Nikolaos S Salemis
Journal:  Breast Care (Basel)       Date:  2012-08       Impact factor: 2.860

3.  Excellent long term oncological outcome in a patient with rare glycogen rich clear cell carcinoma of breast following breast conservation surgery.

Authors:  Ravinder Chowrappa Sanjeeviah; Mahesh Bandimegal; Veena Ramaswamy; Kanmani Govindrao Telkar; Drishti Patil
Journal:  Int J Surg Case Rep       Date:  2022-09-15

Review 4.  Triple-negative breast cancer: A run-through of features, classification and current therapies.

Authors:  Meghana Manjunath; Bibha Choudhary
Journal:  Oncol Lett       Date:  2021-05-05       Impact factor: 2.967

5.  An unusual case of locally advanced glycogen-rich clear cell carcinoma of the breast.

Authors:  Beatriz Martín-Martín; Juan D Berná-Serna; Pilar Sánchez-Henarejos; María J López-Poveda; Juan D Berná-Mestre; José R Rodríguez-García
Journal:  Case Rep Oncol       Date:  2011-09-07

6.  Glycogen Rich Clear Cell Carcinoma (GRCC) of the breast may not have a poor prognosis.

Authors:  Muna M Baslaim; Enaam M Junainah; Hadeel H Ahmad; Anmar F Semilan; Ahmed O Al-Ghamdi; Noora O Rahimuddin; Budoor A Salman
Journal:  Int J Surg Case Rep       Date:  2017-02-27

7.  Immunophenotypes of glycogen rich clear cell carcinoma.

Authors:  Sung Eun Kim; Ja Seung Koo; Woo-Hee Jung
Journal:  Yonsei Med J       Date:  2012-11-01       Impact factor: 2.759

8.  Invasive ductal carcinoma of the breast with clear cell and pseudo-lactating changes.

Authors:  Christopher Ovanez; Joel Crawford; Armand Asarian; Philip Xiao
Journal:  J Surg Case Rep       Date:  2014-07-11

9.  Clear Cell Carcinoma of the Breast: A Rare Breast Cancer Subtype - Case Report and Literature Review.

Authors:  Vilma Ratti; Olivia Pagani
Journal:  Case Rep Oncol       Date:  2015-11-04

Review 10.  Invasive ductal carcinoma of the breast with osteoclast-like giant cells and clear cell features: a case report of a novel finding and review of the literature.

Authors:  Nicole K Zagelbaum; Michael F Ward; Nader Okby; Howard Karpoff
Journal:  World J Surg Oncol       Date:  2016-08-26       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.